Replies to post #77803 on Innovation Pharmaceuticals Inc (IPIX)

[Chemdeps]

Can someone remind me why we are going into Phase II for B-OM and not Phase I....I know I should know this but for some reason it completely escapes me....although I am very happy about it, I cannot for the life of me remember why.

[alwaysdreaming]

My vote is for uplisting so that future CTIX PR's do not fall on the Retail investors/traders ears only.

Uplisting will be what brings us out of this abyss. Then we will see the transition of CTIX shareholders from the 6 figure boys to the 8 and 9 figure boys.

This board will probably get pretty quite at that point. :)

[BonelessCat]

The next 10 weeks:

Bottom line B-ABSSSI Phase 1 results
Bottom line Prurisol Phase 1 bridge study
B-ABSSSI Phase 3 and Prurisol Phase 2/3 FDA meeting
Start B-OM Phase 2 @ MD Anderson
Start K AML @ UofB Phase 1/2
File INDA for B-Otic, B-Aural, and/or B-Diabetic Foot

Possible dose completion Cohort 10 and end of K Phase 1 dosing.
Possible preliminary report following end of enrollment and dosing (Top line data 6 months after end of dosing).
Possible license/partnership for B (1 in 5 chance).
Possible uplist.





Over the next six weeks we have:
Start of the B-OM trial at MD Anderson
Start of K in AML at UofB
Bottom line B 2b results with FDA comments which could be huge!!
Prurisol FDA meeting
And just because of the last PR perhaps even more information on Kevetrin solid tumors p1????
Uplisting???

Anything else? Not sure what the share price will be but the entertainment value is going off the charts for me.